Journal of Cardiovascular Development and Disease (Apr 2022)

Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation

  • Giuseppe Boriani,
  • Saverio Iacopino,
  • Giuseppe Arena,
  • Paolo Pieragnoli,
  • Roberto Verlato,
  • Massimiliano Manfrin,
  • Giulio Molon,
  • Giovanni Rovaris,
  • Antonio Curnis,
  • Giovanni Battista Perego,
  • Antonio Dello Russo,
  • Maurizio Landolina,
  • Marco Vitolo,
  • Claudio Tondo,
  • on behalf of the 1STOP ClinicalService Investigators

DOI
https://doi.org/10.3390/jcdd9050126
Journal volume & issue
Vol. 9, no. 5
p. 126

Abstract

Read online

The aim of this research was to evaluate if patients with chronic kidney disease (CKD) and mild or mild to moderate depression of renal function have an increased risk of atrial fibrillation (AF) recurrences after cryoballoon (CB) ablation. We performed a retrospective analysis of AF patients undergoing pulmonary vein isolation (PVI) by CB. The cohort was divided according to the KDIGO CKD-EPI classification into a (1) normal, (2) mildly decreased, or (3) mild to moderate reduction in estimated glomerular filtration rate (eGFR). Freedom from AF recurrences was the primary endpoint. A total of 1971 patients were included (60 ± 10 years, 29.0% females, 73.6% paroxysmal AF) in the study. Acute success and complication rates were 99.2% and 3.7%, respectively, with no significant differences among the three groups. After a follow-up of 24 months, AF recurrences were higher in the mildly and mild to moderate CKD groups compared to the normal kidney function group (23.4% vs. 28.3% vs. 33.5%, p p = 0.037). In conclusion, a multicenter analysis of AF patients treated with cryoablation revealed mild to moderate reductions in renal functions were associated with a higher risk of AF recurrences. Conversely, the procedural success and complication rates were similar in patients with normal, mildly reduced, or mild to moderate reduction in eGFR.

Keywords